A Practical synthesis of novel Rho-kinase inhibitor, (S)-4-fluoro-5-(2- methyl-1,4-diazepan-1-ylsulfonyl)-isoquinoline

Heterocycles

Volumn 83, Issue 8, 2011, Pages 1771-1781

  Gomi, Noriaki ^a   Ohgiya, Tadaaki ^a   Shibuya, Kimiyuki ^a   Katsuyama, Jyunji ^b   Masumoto, Masayuki ^b   Sakai, Hitoshi ^b  

^a KOWA COMPANY LTD   (Japan)

^b FUJI CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961164273     PISSN: 03855414     EISSN: 18810942     Source Type: Journal    
DOI: 10.3987/COM-11-12230     Document Type: Article

References (26)

1. a) A similar pharmacological effect was obtained in the related compounds, see: K. Mizuno, T. Koide, Y. Fujieda, J. Mori, S. Kondo, J. Matsumoto, Y. Hattori, M. Nishio, and H. Hidaka, ARVO 2007;
2. b) S. Tahara and H. Shimokawa, Yakugaku Zasshi, 2007, 127, 501.
3. a) T. Asano, I. Ikegaki, S. Satoh, Y. Suzuki, M. Shibuya, M. Takayasu, and H. Hidaka, J. Pharmacol. Exp. Ther., 1987, 241, 1033;
4. b) M. Shibuya and Y. Suzuki, BRAIN and NERVE, 1993, 45, 819;
5. c) M. Shibuya, T. Asano, and Y. Sasaki, Acta. Neurochir. Suppl., 2001, 77, 201;
6. d) E. Hu and D. Lee, Expert Opin. Ther. Targets, 2005, 9, 715;
7. e) R. Stavenger, Annu. Rep. Med. Chem., 2008, 43, 87.
8. a) M. J. Huentelman, D. A. Stephan, J. Talboom, J. J. Corneveaux, D. M. Reiman, J. D. Gerber, C. A. Barnes, G. E. Alexander, E. M. Reiman, and H. A. Bimonte-Nelson, Behav. Neurosci., 2009, 123, 218;
9. b) Y. Fukumoto, M. Mohri, K. Inokuchi, A. Ito, Y. Hirakawa, A. Masumoto, Y. Hiraoka, A. Takeshita, and H. Shimokawa, J. Cardiovasc. Pharmacol., 2007, 49, 117;
10. c) H. Fujita, Y. Fukumoto, K. Saji, K. Sugimura, J. Demachi, J. Nawata, and H. Shimokawa, Heart, 2010, 25, 144.
11. A. Roe and C. E. Teague, Jr., J. Am. Chem. Soc., 1951, 73, 687.
12. a) H. Hidaka, A. Matsuura, and T. Matsuzaki, World Patent WO97028130, 1997;
13. b) H. Hidaka and A. Matsuura, World Patent WO99020620, 1999;
14. c) H. Hidaka and H. Muramatsu, World Patent WO99054306, 1999;
15. d) J. L. Peglion, A. Dessinges, C. Poitevin, J. P. Vilaine, N. Villeneuve, C. Thollon, and M. P. Bourguignon, European Patent EP1122254, 2001.
16. a) H. T. Clarke, G. S. Babcock, and T. F. Murray, Org. Synth., 1941, Coll. Vol. 1, 84;
17. b) C. Gerard, L. C. McPhail, A. Marfat, N. P. Stimler-Gerard, D. A. Bass, and C. E. McCall, J. Clin. Invest., 1986, 77, 61;
18. c) A. Morikawa, T. Sone, and T. Asano, J. Med. Chem., 1989, 32, 42.
19. a) M. S. Morgan and L. H. Cretcher, J. Am. Chem. Soc., 1948, 70, 375;
20. b) J. Y. Q. Lai, Y. Ferguson, and M. Jones, Synth. Commun., 2003, 33, 3427.
21. M. Furukawa, M. Nishikawa, Y. Inaba, Y. Noguchi, T. Okawara, and T. Hitoshi, Chem. Pharm. Bull., 1981, 29, 623.
22. a) I. J. Krauss and J. L. Leighton, Org. Lett., 2003, 5, 3201;
23. b) C. A. Olsen, C. Christensen, B. Nielsen, M. M. Farah, M. Witt, R. P. Clausen, J. L. Kristensen, H. Franzyk, and J. W. Jaroszewski, Org. Lett., 2006, 8, 3371;
24. c) F. Crestey, M. Witt, K. Frydenvang, D. Stærk, J. W. Jaroszewski, and H. Franzyk, J. Org. Chem., 2008, 73, 3566;
25. d) J. A. Groeper, J. B. Eaglesa, and S. R. Hitchcock, Tetrahedron:Asymmetry, 2009, 20, 1969;
26. J. R. Henry, L. R. Marcin, M. C. Mcintosh, P. M. Scola, G. D. Harris, Jr., and S. M. Weinreb, Tetrahedron Lett., 1989, 30, 5709.